Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Melanoma-associated antigen 8 (MAGEA8) is a member of the MAGEA gene family, encoding cancer/testis antigens. It is typically expressed in various tumors but silent in most normal tissues except testis and placenta. MAGEA8 is implicated in tumorigenesis and may play roles in embryonal development and tumor progression. It serves as a target for cancer immunotherapy due to its tumor-restricted expression.
Targeted by experimental immunotherapies such as peptide vaccines, DNA vaccines, dendritic cell therapies, and mRNA-based approaches.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melanoma-associated antigen 8 (MAGEA8).